Home / Intelligence / Webinars / A Massive Change Ahead in CRM: Predictions and Implications for Pharma
Available On Demand
Are you ready for the transition and change being forced on the pharmaceutical industry given the unprecedented Customer Relationship Management (CRM) changes announced by Veeva, Salesforce and IQVIA?
The status quo is not an option. Life science companies are being forced to evaluate the implications on their customer strategy and operations as the CRM is one piece of an increasingly integrated ecosystem. The CRM decision will influence commercial and medical data strategy and management, commercial interface architectures, marketing automation and customer engagement, integration of Next Best Action (NBA) tools, reporting and intelligence.
While there are still many unknowns, proactive companies are pressure testing their assumptions now to make sure they are strategically and operationally ready. Join the Trinity Life Sciences’ team for an engaging panel discussion on what pharma companies should be thinking about in advance of the CRM shift.
Key Webinar Topics
- What steps should companies take to prepare for this change?
- How will pharma companies be impacted?
- What actions should companies take now to ensure they have the right approach to data strategy and management?
- What criteria should companies be considering as they evaluate which path to choose?
- Is it necessary to make a decision now? What is the potential downside of delaying?
Featuring
Aparna Deshpande
Senior Partner &
Head of Analytics and Insights
Nancy R. Phelan
Senior Vice President & Head of
Customer Engagement
Frank Lane
Senior Vice President &
Head of Data Orchestration
Lisa Klein
Vice President,
Field Operations, Commercial Insights & Advanced Analytics
Abbey Bernardi
Senior Director,
New Products & Strategy
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
Webinars
Unlocking Medical Impact with AI
September 18, 2025 | 1:00 – 1:45 PM ET
Medical Affairs teams are under growing pressure to deliver faster insights, smarter engagement, and measurable value—yet many are limited by manual processes, fragmented data, and time-intensive workflows. Join us for the next webinar in our “AI Innovations in Life Sciences” series, where Trinity experts will show how it is possible with AI to unlock deeper, novel insights, power efficient workflows, and drive greater impact in the Medical Affairs field and headquarters functions.
Sign Up Now
Blog
Trinity Life Sciences Unveils Groundbreaking Trinity Digital Affinity, Powered by DeepIntent, to Transform HCP Engagement for Life Sciences
In today’s fast-evolving digital landscape, life sciences companies face a critical challenge: reach the right healthcare professionals (HCPs) with the right message, through the right channels, at the right time. At Trinity Life Sciences, we’re proud to help our clients meet that challenge head-on with the launch of Trinity Digital Affinity, powered by DeepIntent. This […]
Read More
Analyst Reports
Trinity Life Sciences Secures Prestigious Leader Position in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI & Analytics Excellence
Trinity Life Sciences is a Leader in Everest Group’s 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment—with its distinction rooted in exceptional, tangible outcomes delivered for clients across the life sciences sector.
Read More